Ms. Morrison (for herself, Mr. Lawler, Ms. Matsui, Mr. Cline, Mr. Fitzpatrick, and Mr. Bacon) introduced the following bill; which was referred to the Committee on Energy and Commerce
To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Allergen Disclosure In Non-food Articles Act. H.R. 3821. 119th
Cong., 1st
sess., Introduced in House June 6, 2025. https://www.govinfo.gov/app/details/BILLS-119hr3821ih.
APA
Congress, House of Representatives (2025, June 6). Allergen Disclosure In Non-food Articles Act (H.R. 3821 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr3821ih.
MLA
United States, Congress, House of Representatives. Allergen Disclosure In Non-food Articles Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr3821ih. 119th Congress, H.R. 3821, Introduced in House 6 Jun. 2025.
Bluebook
H.R.3821 - 119th Congress (2025-2026): Allergen Disclosure In Non-food Articles Act, H.R.3821, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr3821ih.
